Chenkwang Science

Chenkwang Science is a for-profit international organization based in Gunpo-si, Gyeonggi-do, South Korea, registered to receive federal awards since April 2017. The company specializes in medical and microbiological reagents, serving as a critical supplier of diagnostic and analytical laboratory materials to the U.S. Department of Defense. Chenkwang Science has established itself as a trusted vendor for military medical treatment facilities throughout the Asia-Pacific region, particularly in South Korea and Japan, where it provides specialized testing supplies and consumables essential to military medical operations.

Chenkwang Science has received federal contract awards exclusively from defense and logistics agencies without any set-aside designations. The primary funding agencies awarding contracts have been the Defense Health Agency, Defense Logistics Agency Troop Support Pacific, the Department of the Army Medical Command, and the Bureau of East Asian and Pacific Affairs. The company's contract work has centered on the provision of Biomerieux reagents and laboratory supplies, including microbial identification reagents, antibiotic susceptibility testing materials, and microbiological media to support bacterial pathogen identification and antimicrobial resistance testing at U.S. military medical facilities. Notable end-use locations include Brian Allgood Army Community Hospital and United States Naval Hospital Okinawa. Contract awards have ranged from small delivery orders valued at $862 to larger orders exceeding $55,000, with firm fixed-price contract types predominating. Chenkwang Science has consistently performed as a prime contractor on all awarded contracts with no identified subcontractors, and all performance has taken place in South Korea. The contract award history demonstrates consistent year-over-year engagement with federal agencies from 2021 through 2025, indicating sustained demand for the company's specialized laboratory supply capabilities in the Pacific region.

Chenkwang Science holds a single-award Indefinite Delivery Contract with the Defense Health Agency valued at $232,645.53, effective October 1, 2023, through September 30, 2028. The contract encompasses a one-year base period plus four one-year option periods and was awarded without full and open competition due to the contractor's unique capabilities in supplying specialized medical reagents. Under this IDV, the Defense Health Agency has issued multiple firm fixed-price delivery orders supporting the Biological Defense Analytical and Assessment Center at Brian D. Allgood Army Community Hospital in South Korea. Recent delivery orders issued under this vehicle include a $33,997.95 delivery order awarded October 1, 2025, for completion by September 30, 2026, and a $30,586.50 delivery order issued October 1, 2024, through September 30, 2025. The IDV supplies Biomerieux reagents and microbiological testing consumables to enable bacterial pathogen identification, antimicrobial resistance testing, and microbiological assessment capabilities for U.S. military medical treatment facilities across the Asia-Pacific region. All deliveries under this contract are performed in South Korea, with no set-aside designation applied to the underlying IDV or its delivery orders.